- Home
- QNCX vs CBFV Comparison
QNCX vs CBFV Comparison
Compare QNCX & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- CBFV
- Stock Information
- Founded
- QNCX 2012
- CBFV 1901
- Country
- QNCX United States
- CBFV United States
- Employees
- QNCX 36
- CBFV N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- CBFV Major Banks
- Sector
- QNCX Health Care
- CBFV Finance
- Exchange
- QNCX Nasdaq
- CBFV Nasdaq
- Market Cap
- QNCX 139.2M
- CBFV 153.2M
- IPO Year
- QNCX 2019
- CBFV N/A
- Fundamental
- Price
- QNCX $2.68
- CBFV $35.37
- Analyst Decision
- QNCX Strong Buy
- CBFV Buy
- Analyst Count
- QNCX 4
- CBFV 2
- Target Price
- QNCX $7.75
- CBFV $36.00
- AVG Volume (30 Days)
- QNCX 551.1K
- CBFV 5.4K
- Earning Date
- QNCX 11-12-2025
- CBFV 10-23-2025
- Dividend Yield
- QNCX N/A
- CBFV 2.96%
- EPS Growth
- QNCX N/A
- CBFV N/A
- EPS
- QNCX N/A
- CBFV 0.51
- Revenue
- QNCX N/A
- CBFV $39,329,000.00
- Revenue This Year
- QNCX N/A
- CBFV $10.71
- Revenue Next Year
- QNCX N/A
- CBFV $12.52
- P/E Ratio
- QNCX N/A
- CBFV $68.98
- Revenue Growth
- QNCX N/A
- CBFV N/A
- 52 Week Low
- QNCX $0.72
- CBFV $26.01
- 52 Week High
- QNCX $2.85
- CBFV $35.37
- Technical
- Relative Strength Index (RSI)
- QNCX 83.72
- CBFV 68.38
- Support Level
- QNCX $1.61
- CBFV $32.70
- Resistance Level
- QNCX $1.84
- CBFV $34.50
- Average True Range (ATR)
- QNCX 0.21
- CBFV 0.75
- MACD
- QNCX 0.10
- CBFV 0.18
- Stochastic Oscillator
- QNCX 87.94
- CBFV 100.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.